# Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture

Study · id `cardio:ct-nct07360899` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07360899](<https://clinicaltrials.gov/study/NCT07360899>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07360899

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07360899. Allocation not applicable; no masking; primary purpose treatment. Start 2025-12-01 (actual); primary completion 2026-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07360899, source copy `cardio:ctgov-nct07360899-2026-01-22`, retrieved 2026-10-26)
- Started: 2025-12-01 (actual) (ClinicalTrials.gov record NCT07360899, source copy `cardio:ctgov-nct07360899-2026-01-22`, retrieved 2026-10-26)
- Primary completion: 2026-04-30 (anticipated) (ClinicalTrials.gov record NCT07360899, source copy `cardio:ctgov-nct07360899-2026-01-22`, retrieved 2026-10-26)
- Completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT07360899, source copy `cardio:ctgov-nct07360899-2026-01-22`, retrieved 2026-10-26)
- Countries: Serbia (ClinicalTrials.gov record NCT07360899, source copy `cardio:ctgov-nct07360899-2026-01-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07360899-2026-01-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture
- Acronym: ATRI-LASH
- Condition: ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION
- Condition: Atrial Fibrillation (AF)
- Condition: Mitral Valve Surgery
- Condition: Stroke (in Patients With Atrial Fibrillation)
- Condition: Anticoagulant Therapy
- Intervention (Device): LAA closure using the AtriLASH
- Lead sponsor: Institute of Cardiovascular Diseases, Vojvodina
- Lead sponsor class: OTHER
- Collaborator: Institute for Cardiovascular Diseases Dedinje
- Collaborator class: OTHER
- Collaborator: KBC Rebro Zagreb
- Collaborator class: UNKNOWN
- Collaborator: Clinical Centre of Serbia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Institute of Cardiovascular Diseases, Vojvodina (`cardio:org-institute-of-cardiovascular-diseases-vojvodina`)
- Registry lists this organization as a collaborator: Clinical Centre of Serbia (`cardio:org-clinical-centre-of-serbia`)

## Provenance

Content hash: 92020dc7456edc5d9a94d9380eafe4a011191f892d6646f7524b27b56931eeba
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
